NCT04235179View on ClinicalTrials.gov

Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 16, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2026

Conditions
Endometrial Cancer
Interventions
RADIATION

SABR

SABR to a dose of 30Gy/5 to the pelvis (vaginal and paravaginal tissues as well as regional lymph nodes)

Trial Locations (1)

Unknown

RECRUITING

King Saud University Medical City, Riyadh

All Listed Sponsors
lead

King Saud University

OTHER

NCT04235179 - Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer | Biotech Hunter | Biotech Hunter